Company Monitoring Page for Teva-Pharmaceutical

latest headlines for company on cafepharma

Teva, AbbVie's Allergan hand over $161M to settle opioid lawsuit in West Virginia
Fierce Pharma
Wed, 05/25/22 - 11:36 pm
Tags:
AbbVie, Allergan, Teva Pharmaceutical, legal, opioids, opioid crisis
J&J's crown jewel Stelara faces another potential rival as biosim player Alvotech touts trial win
Fierce Pharma
Tue, 05/24/22 - 04:31 pm
Tags:
Alvotech, Teva Pharmaceutical, JNJ, Stelara, AVT04, biosimilars, psoriasis
AbbVie, Teva looking to settle nationwide opioid litigation for $5B+: Bloomberg
Fierce Pharma
Wed, 05/11/22 - 11:05 pm
Tags:
AbbVie, Allergan, Teva Pharmaceutical, opioids, opioid crisis, legal
Teva cuts sales guidance amid competitive pressures, currency exchange woes
Fierce Pharma
Wed, 05/4/22 - 10:40 am
Tags:
Teva Pharmaceutical, earnings
Teva settlement prevents Lupin from launching its Austedo generic until 2033
Fierce Pharma
Mon, 05/2/22 - 06:34 pm
Tags:
Teva Pharmaceutical, tardive dyskinesia, Austedo, Lupin, generics
Late-stage pain pipeline refuses to swell
EP Vantage
Tue, 04/26/22 - 10:29 pm
Tags:
painkillers, Vertanical, Teva Pharmaceutical, Regeneron, Ampio Pharmaceuticals, Biogen, Eli Lilly, Vertex Pharmaceuticals, AstraZeneca, Acadia Pharmaceuticals
Teva receives CRL for reformulated schizophrenia drug developed with French biotech
Endpoints
Wed, 04/20/22 - 10:48 am
Tags:
Teva Pharmaceutical, MedinCell, schizophrenia, FDA, complete response letter
Teva, AbbVie ink opioid settlements worth nearly $330M with Florida
Fierce Pharma
Thu, 03/31/22 - 10:25 am
Tags:
Teva Pharmaceutical, AbbVie, legal, Florida, opioids, opioid crisis
Teva recalls one lot of leukemia med after finding particulates in vial
Fierce Pharma
Wed, 03/30/22 - 11:01 am
Tags:
Teva Pharmaceutical, leukemia, product recalls
Teva suffers setback on in-house asthma program as a PhII study is halted early due to futility
Endpoints
Wed, 03/23/22 - 11:06 am
Tags:
Teva Pharmaceutical, clinical trials, asthma, TEV-48574
Rhode Island reaches $28.5-million in settlements with opioid manufacturers
The Providence Journal, RI
Mon, 03/21/22 - 10:25 pm
Tags:
opioids, opioid crisis, Rhode Island, Teva Pharmaceutical, Allergan
Bristol Myers Squibb's Revlimid finally faces competition in the U.S. with Teva's generic launch
Fierce Pharma
Mon, 03/7/22 - 10:51 pm
Tags:
Bristol Myers Squibb, Revlimid, Multiple Myeloma, generics, Teva Pharmaceutical
Teva, Endo and more back on the hook in San Francisco opioid trial
Fierce Pharma
Thu, 02/24/22 - 11:00 pm
Tags:
opioids, San Francisco, Teva Pharmaceutical, Endo International, AbbVie, Allergan
Is the battle over 'skinny' generic labels headed to the Supreme Court?
Endpoints
Wed, 02/16/22 - 11:10 pm
Tags:
Teva Pharmaceutical, generics, skinny labels
Court sides with Teva over Emergent in generic Narcan suit
Endpoints
Tue, 02/15/22 - 11:36 pm
Tags:
Teva Pharmaceutical, legal, Emergent BioSolutions, generics, Narcan, opioids
Teva execs claim mixed winning streak in pricey opioids court battle — as permanent peace remains elusive
Endpoints
Wed, 02/9/22 - 10:57 pm
Tags:
Teva Pharmaceutical, earnings, Kåre Schultz, legal, opioids
Teva forks over $150M to settle Texas opioid suit
Fierce Pharma
Mon, 02/7/22 - 11:18 pm
Tags:
Teva Pharmaceutical, legal, Texas, opioids
Teva survey finds COVID has 'widened the chasm' on health disparities
Fierce Pharma
Tue, 02/1/22 - 10:38 am
Tags:
Teva Pharmaceutical, health inequities, COVID-19, pandemic
Teva and Novartis’ Sandoz launch Narcan generics on same day, brand marketer Emergent remains in play
Endpoints
Wed, 01/5/22 - 10:47 pm
Tags:
Teva Pharmaceutical, Novartis, Sandoz, generics, Narcan, Emergent BioSolutions
Pfizer, GSK and Teva lead 2022's round of January drug price hikes: GoodRx
Fierce Pharma
Tue, 01/4/22 - 10:43 pm
Tags:
Pfizer, GSK, Teva Pharmaceutical, drug pricing

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.